483
Marc Miller, M.D.FDA 483 - Marc Miller, M.D. - March 08, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Marc Miller, M.D., a clinical investigator in New York, revealed one significant observation. The firm failed to ensure that the sponsor received updated financial disclosure information from participating investigators when a study's funding source changed. This indicates a lapse in maintaining complete and accurate financial records related to clinical studies.
Open in Dashboard
ID · 70f91a66-26e7-43bb-9dc9-59aa1ea9d8ec